Title |
Anti‐vascular endothelial growth factor for neovascular glaucoma
|
---|---|
Published in |
Cochrane database of systematic reviews, October 2013
|
DOI | 10.1002/14651858.cd007920.pub2 |
Pubmed ID | |
Authors |
Arathi Simha, Andrew Braganza, Lekha Abraham, Prasanna Samuel, Kristina Lindsley |
Abstract |
Neovascular glaucoma (NVG) is a potentially blinding secondary glaucoma. It is caused by the formation of abnormal new blood vessels which prevent normal drainage of aqueous from the anterior segment of the eye. Anti-vascular endothelial growth factor (anti-VEGF) agents are specific inhibitors of the primary mediators of neovascularization. Studies have reported the effectiveness of anti-VEGFs for the control of intraocular pressure (IOP) in NVG. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Practitioners (doctors, other healthcare professionals) | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 3% |
Unknown | 39 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 7 | 18% |
Student > Master | 6 | 15% |
Student > Bachelor | 5 | 13% |
Student > Postgraduate | 3 | 8% |
Lecturer | 2 | 5% |
Other | 7 | 18% |
Unknown | 10 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 40% |
Psychology | 4 | 10% |
Agricultural and Biological Sciences | 1 | 3% |
Computer Science | 1 | 3% |
Economics, Econometrics and Finance | 1 | 3% |
Other | 5 | 13% |
Unknown | 12 | 30% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 January 2020.
All research outputs
#5,264,158
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#7,177
of 11,499 outputs
Outputs of similar age
#45,060
of 220,222 outputs
Outputs of similar age from Cochrane database of systematic reviews
#141
of 219 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one is in the 37th percentile – i.e., 37% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 220,222 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 219 others from the same source and published within six weeks on either side of this one. This one is in the 35th percentile – i.e., 35% of its contemporaries scored the same or lower than it.